Literature DB >> 11911357

Clinical relevance of cagE gene from Helicobacter pylori strains in Japan.

Kanako Fukuta1, Takeshi Azuma, Yoshiyuki Ito, Hiroyuki Suto, Yoshihide Keida, Hiroyuki Wakabayashi, Akiharu Watanabe, Masaru Kuriyama.   

Abstract

It has been reported that H. pylori-containing cagE was associated with duodenal ulcer. The aims of the present study were to clarify the association between the cagE gene and clinical outcome and to analyze the relationship between the cagE gene and two other virulence factors--cagA and vacA--in two areas in Japan (Fukui and Okinawa) where the prevalence of duodenal ulcer and gastric cancer risk are quite different. Eighty of 81 isolates possessed the cagE gene, and all isolates possessed the cagA gene. The vacA genotype s1c/ml was a major genotype in both areas in Japan. There was no significant association between cagE, cagA status, or vacA genotype and clinical outcome. Phylogenetic analysis of the cagE gene indicated that most Japanese isolates formed a different cluster from strains isolated in the West with an association with the vacA genotype. In conclusion, the strains with cagE, cagA, and the s1c/ml genotype of vacA are predominant in Japan regardless of clinical outcome and construct a different phylogenetic cluster from those in the West.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911357     DOI: 10.1023/a:1017949026509

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

3.  Geographic distribution of vacA allelic types of Helicobacter pylori.

Authors:  L J Van Doorn; C Figueiredo; F Mégraud; S Pena; P Midolo; D M Queiroz; F Carneiro; B Vanderborght; M D Pegado; R Sanna; W De Boer; P M Schneeberger; P Correa; E K Ng; J Atherton; M J Blaser; W G Quint
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

4.  Emergence of recombinant strains of Helicobacter pylori during human infection.

Authors:  D Kersulyte; H Chalkauskas; D E Berg
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

5.  Expanding allelic diversity of Helicobacter pylori vacA.

Authors:  L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

6.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

Authors:  N Akopyanz; N O Bukanov; T U Westblom; S Kresovich; D E Berg
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

7.  Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.

Authors:  W Tee; J R Lambert; B Dwyer
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.

Authors:  M Hirai; T Azuma; S Ito; T Kato; Y Kohli; N Fujiki
Journal:  Int J Cancer       Date:  1994-01-02       Impact factor: 7.396

9.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

Review 10.  Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell.

Authors:  A Covacci; R Rappuoli
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  3 in total

1.  Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study.

Authors:  Tung L Nguyen; Tomohisa Uchida; Yoshiyuki Tsukamoto; Dung T Trinh; Long Ta; Bang H Mai; Song H Le; Ky D Thai; Dung D Ho; Hai H Hoang; Takeshi Matsuhisa; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Toshio Fujioka; Yoshio Yamaoka; Masatsugu Moriyama
Journal:  BMC Gastroenterol       Date:  2010-09-30       Impact factor: 3.067

2.  Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding.

Authors:  Chin-Lin Perng; Hwai-Jeng Lin; Wen-Ching Lo; Guan-Ying Tseng; I-Chen Sun; Yueh-Hsing Ou
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan.

Authors:  Hwai-Jeng Lin; Chin-Lin Perng; Wen-Ching Lo; Chew-Wun Wu; Guan-Ying Tseng; Anna-Fen-Yau Li; I-Chen Sun; Yueh-Hsing Ou
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.